News

Small caps round-up: Indigovision, Waterford Wedgwood, Real Estate Opportunities

08 November 2007 09:31:00

Indigovision Group said it is confident the current year should show strong growth in sales overall and will see a "material" improvement in operating results.

The group said it has seen a strong first quarter with sales for the thirteen weeks to 28th October up 38%. Order intake by value in the first quarter was up 68%.

"Along with higher sales, gross margins in the first quarter have also been ahead of last year, continuing the strong margin performance seen in last year's second half," said the group.

Waterford Wedgwood said results for the first half have slowed with revenue down and pre-tax losses increasing.

Sales for the half-year were down 10% to €317.4m, while losses increased 36.8% to €57.5m.

"There was genuine consumer enthusiasm for our products, especially in the US, but sales were affected by product shortages over the six months to September, and adverse currency fluctuations," said the group.

A Real Estate Opportunities subsidiary has been selected as a joint venture partner by Drogheda Port Company to develop Ireland's new deep-water Port at Bremore following an open tender process.

"Current estimates of its total development costs are in the order of €300m," said the group.

Worthington Group said its reduced operations gave it a profit of £20,000 in the first half.

"Several strategy changes have been considered during the period to better utilise our cash reserves but because of our asset value any proposed changes would probably require a Class 1 circular to shareholders and possibly Pension Regulator approval, incurring significant costs for the group," it said

Biopharmaceutical contract manufacturer Angel Biotechnology announced an extension to its GMP manufacturing contract with ReNeuron Group. Terms of the contract were not disclosed.

Under the existing contract, started in the second quarter this year, Angel is manufacturing to GMP a cell bank and clinical grade material for ReNeuron's ReN001 cell line for stroke. The original contract has been extended to undertake additional cell expansion work.

Canadian-based oil and gas exploration company Bankers Petroleum said "there is nothing known at this time that could be contributing to the company's recent rise in share price."

Shares in Condor Resources doubled after the oil explorer said drilling at the El Cacao Prospect in Nicaragua showed at least two mineralised zones containing high grade shoots over a strike length of 330 metres.

"The results from the initial drilling phase at the 100% owned El Cacao Project, have again confirmed that better grades and widths usually occur at depth below sometimes meagre surface results in epithermal systems," said CEO Nigel Ferguson.

Crosby Capital narrowed losses in the third quarter to $28.2m from $47.3m in the same period last year. Turnover rose to $21.6m from $6.4m previously.

Gatekeeper Systems expects total revenues for the current financial year to be in the range of $31m to $32m. Net income is expected to be in the range of $2.2m to $2.5m.

Television production and distribution company RDF Media said ITV has confirmed lifting the temporary suspension on new commissions and normal commissioning relations have resumed with immediate effect.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.